Sign inGet started

Chell Jeffrey W.

Insider CIK 1738374 · ATNM Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ATNM Actinium Pharmaceuticals, A Award deriv2026-09-022026-09-0492,400— $092,400SEC↗
ATNM Actinium Pharmaceuticals, A Award2026-09-022026-09-0461,600— $061,600SEC↗
ATNM Actinium Pharmaceuticals, A Award deriv2026-09-022026-09-0492,400— $092,400SEC↗
ATNM Actinium Pharmaceuticals, A Award2026-09-022026-09-0461,600— $061,600SEC↗
ATNM Actinium Pharmaceuticals, D To issuer deriv2025-03-312025-04-022,500— $00SEC↗
ATNM Actinium Pharmaceuticals, D To issuer deriv2025-03-312025-04-022,500— $00SEC↗
ATNM Actinium Pharmaceuticals, D To issuer deriv2025-03-312025-04-028,333— $00SEC↗
ATNM Actinium Pharmaceuticals, D To issuer deriv2025-03-312025-04-028,333— $00SEC↗
ATNM Actinium Pharmaceuticals, D To issuer deriv2025-03-312025-04-0218,351— $00SEC↗
ATNM Actinium Pharmaceuticals, D To issuer deriv2025-03-312025-04-0272,156— $00SEC↗
ATNM Actinium Pharmaceuticals, D To issuer deriv2025-03-312025-04-0270,311— $00SEC↗
ATNM Actinium Pharmaceuticals, A Award deriv2023-12-282023-12-2970,311— $070,311SEC↗
ATNM Actinium Pharmaceuticals, A Award deriv2022-07-012022-07-0172,156— $072,156SEC↗
ATNM Actinium Pharmaceuticals, A Award deriv2021-09-012021-09-0318,351— $018,351SEC↗
ATNM Actinium Pharmaceuticals, A Award deriv2020-08-122020-08-148,333— $08,333SEC↗
ATNM Actinium Pharmaceuticals, A Award deriv2019-07-122019-07-16250,000$0.23 $57.5K250,000SEC↗
ATNM Actinium Pharmaceuticals, A Award deriv2018-07-132018-07-1775,000$0.78 $58.5K75,000SEC↗